A phase I study of lenalidomide and weekly docetaxel in patients with advanced solid tumors.

被引：0
|
作者：
Papadopoulos, K
Mendelson, D
Preston, GG
Lopez, AM
Ricart, AD
Schwartz, G
Needle, MN
Gordon, MS
机构：
[1] Inst Drug Dev, San Antonio, TX USA
[2] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA
[3] Arizona Canc Ctr, Scottsdale, AZ USA
[4] Brooke Army Med Ctr, San Antonio, TX USA
[5] Celgene, Summit, NJ USA
来源：
CLINICAL CANCER RESEARCH | 2005年 / 11卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：9116S / 9116S
页数：1
相关论文
共 50 条
  • [31] Phase I trial to assess the safety and pharmacokinetics of afatinib and weekly vinorelbine in patients with advanced solid tumors.
    Hollebecque, Antoine
    Bahleda, Rastislav
    Berge, Yann
    Massard, Christophe
    Uttenreuther-Fischer, Martina Maria
    De-Montserrat, Helene
    Tschoepe, Inga
    Soria, Jean-Charles
    Delord, Jean-Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [32] Phase I study of ispinesib in combination with carboplatin in patients with advanced solid tumors.
    Jones, S. F.
    Plummer, E. R.
    Burris, H. A.
    Razak, A. R.
    Meluch, A. A.
    Bowen, C. J.
    Williams, D. H.
    Hodge, J. P.
    Dar, M. M.
    Calvert, A. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 85S - 85S
  • [33] Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumors.
    Hollebecque, Antoine
    Bahleda, Rastislav
    Thery, Jean Christophe
    Faivre, Laura
    Le Deley, Marie-Cecile
    Paci, Angelo
    Varga, Andrea
    Gazzah, Anas
    Massard, Christophe
    Poinsignon, Vianney
    Malekzadeh, Katty
    Ribrag, Vincent
    Angevin, Eric
    Postel-Vinay, Sophie
    Gomez-Roca, Carlos Alberto
    Gharib, Myriam
    Dufour, Fabienne
    Soria, Jean-Charles
    Spano, Jean-Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [34] Phase I study of MEDI0639 in patients with advanced solid tumors.
    Falchook, Gerald Steven
    Dowlati, Afshin
    Naing, Aung
    Gribbin, Matthew Joseph
    Jenkins, David William
    Chang, Linda L.
    Lai, Dominic W.
    Smith, David C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [35] Phase I study of sequential sapacitabine and seliciclib in patients with advanced solid tumors.
    Shapiro, Geoffrey
    Kwak, Eunice Lee
    Cleary, James M.
    Tolaney, Sara
    Gandhi, Leena
    Clark, Jeffrey W.
    Wolanski, Andrew
    Frame, Sheelagh
    Rodig, Scott J.
    Chiao, Judy H.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [36] Phase I trial of docetaxel given every 3 weeks and daily lenalidomide in patients with advanced solid tumors
    Sanborn, Sharon L.
    Gibbons, Joseph
    Krishnamurthi, Smitha
    Brell, Joanna M.
    Dowlati, Afshin
    Bokar, Joseph A.
    Nock, Charles
    Horvath, Nancy
    Bako, Jacob
    Remick, Scot C.
    Cooney, Matthew M.
    INVESTIGATIONAL NEW DRUGS, 2009, 27 (05) : 453 - 460
  • [37] Phase I trial combining motexafin gadolinium with docetaxel in the treatment of advanced solid tumors.
    Phan, S
    Messina, P
    Buffan, M
    Salemi, ML
    Pandya, K
    Wilmot, JP
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 244S - 244S
  • [38] Phase I trial of docetaxel given every 3 weeks and daily lenalidomide in patients with advanced solid tumors
    Sharon L. Sanborn
    Joseph Gibbons
    Smitha Krishnamurthi
    Joanna M. Brell
    Afshin Dowlati
    Joseph A. Bokar
    Charles Nock
    Nancy Horvath
    Jacob Bako
    Scot C. Remick
    Matthew M. Cooney
    Investigational New Drugs, 2009, 27 : 453 - 460
  • [39] Phase I trial of daily lenalidomide and docetaxel given every three weeks in patients with advanced solid tumors
    Sanborn, S. L.
    Cooney, M.
    Gibbons, J.
    Brell, J.
    Savvides, P.
    Krishnamurthi, S.
    Bokar, J.
    Horvath, N.
    Ness, A.
    Remick, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [40] Phase I study of regorafenib and sildenafil in advanced solid tumors.
    Poklepovic, Andrew Stewart
    Gordon, Sarah W.
    McGuire, William P.
    Thacker, Leroy R.
    Deng, Xiaoyan
    Tombes, Mary Beth
    Shrader, Ellen
    Ryan, Alison A.
    Kmieciak, Maciej
    Dent, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345